In cetuximab resistant CRC, hnRNPA2B1 binds to lncRNA MIR100HG through the RRM2 domain and stabilizes TCF7L2 mRNA, enhancing Wnt/β-catenin signaling (39). This evidence concerns the gene HNRNPA2B1 and colorectal carcinoma.